Clover Corporation Limited (CLV), an ASX-listed company, develop and produce encapsulated bioactive ingredients, specialising in nutritional oils for infant formula, medical foods, and functional foods. The Company deliver nutritional solutions that enhance product stability, bioavailability, and health benefits.
| ASX Code | CLV |
| Website | http://www.clovercorp.com.au |
| Industry/Sector | Specialty Chemicals |
| Market Cap ($M) | 148 |
| CLV Share Price | $0.890 |
| Day High | $0.920 |
| Day Low | $0.880 |
| Last Close | $0.890 |
| CLV Share Price Movement | - ( No change ) |
| Distribution Type | Dividend | Franking | Ex-dividend date | Payment date | Current Price+ | Price 7D Avg | Dividend Yield |
|---|---|---|---|---|---|---|---|
| Result | 1¢ | 100% | 15 Apr 2026 | 30 Apr 2026 | - | - | - |
| HFResult | 1¢ | 100% | 20 Oct 2025 | 20 Nov 2025 | - | - | - |
| Result | 0.75¢ | 100% | 9 Apr 2025 | 24 Apr 2025 | - | - | - |
See all dividends from Clover Corporation Limited (CLV) or use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.
| Year to Jul | NPAT | EPS | EPS chg (%) | PER | DPS | Yield (%) | Franking (%) |
|---|---|---|---|---|---|---|---|
| 2025A | $7.02 | $4.20 | 361.50% | 11.10 | 1.80 | 3.80% | 100.0% |
| 2024A | $1.52 | $0.90 | -75.50% | 83.80 | 0.80 | 1.00% | 100.0% |
| 2023A | $6.21 | $3.70 | -13.30% | 32.70 | 1.50 | 1.20% | 100.0% |
| Company | Mkt Cap | EPS Growth (%) | P/E (%) | Dividend Yield (%) | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 2023 A | 2024 A | 2025 A | 2023 A | 2024 A | 2025 A | 2023 A | 2024 A | 2025 A | ||
| Clover Corporation Limited (CLV) | $154M | 3.6154 | 0.0000 | 0.0000 | 22.0238 | 0.0000 | 0.0000 | 1.89% | 0.00% | 0.00% |
| Earnings | P/E Ratio | P/B Ratio | P/E Growth | |
|---|---|---|---|---|
| Company | 0.23 | 21.20 | 2.06 | 0.00 |
| Market | 0.36 | 12.90 | 1.15 | 0.70 |
| Sector | 1.46 | 13.70 | 1.63 | 0.29 |
| Name | Position | Start Date |
|---|---|---|
| Mr Peter J Davey | Chief Executive Officer, Managing Director | 16 Dec 2014 |
| Mr Ian David Glasson | Non-Executive Director | 1 Feb 2017 |
| Ms Toni Brendish | Non-Executive Director | 20 Oct 2020 |
| Dr Simon Green | Non-Executive Director | 20 Oct 2020 |
| Ms Fiona Pearse | Non-Executive Director | 1 Aug 2025 |
| Mr Rupert Anthony Harrington | Non-Executive Director, Non-Executive Chairman | 1 Jul 2015 |
| Date of change | Director | Buy/Sell | Security Type | Qty | Trade Price | Value |
|---|---|---|---|---|---|---|
| 31 Oct 2025 | ALLIBON, Andrew | Buy | Indirect Shares | 2,447 | $0.650 | $1,591.000 |
| 28 Oct 2025 | PEARSE, Fiona | Buy | Indirect Shares | 62,996 | $0.636 | $40,050.000 |
| 27 Oct 2025 | PEARSE, Fiona | Buy | Indirect Shares | 31,000 | $0.650 | $20,165.000 |
See all changes in directors' interest & trades for Clover Corporation Limited (CLV) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.
| Name | Position |
|---|---|
| Andrew Allibon | Chief Financial Officer,Company Secretary |
| Date | Event |
|---|---|
| 23 March 2027 | Report (Interim) |
| 16 October 2026 | Report (Annual) |
| 22 September 2026 | Report (Annual) |
| 22 September 2026 | Report (Prelim) |
DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.
Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate,
complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892)
and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and,
if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest.
No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser.
Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.